Endometrial effects of long-term low-dose administration of RU486
article
OA: closed
CC0
⤵ 22 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (24)
- Accelerated dissolution of luteal-endometrial integrity by the administration of antagonists of gonadotropin-releasing hormone and progesterone to late-luteal phase women via openalex
- Endocrine responses to long-term administration of the antiprogesterone RU486 in patients with pelvic endometriosis via openalex
- Immunohistochemical analysis of estrogen and progesterone receptors in endometriosis: comparison with normal endometrium during the menstrual cycle and the effect of medical therapy via openalex
- Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486. via openalex
- Interruption of endometrial maturation without hormonal changes by an antiprogesterone during the first half of luteal phase of the menstrual cycle: a contraceptive potential via openalex
- Late Luteal Phase Administration of RU486 for Three Successive Cycles Does Not Disrupt Bleeding Patterns or Ovulation* via openalex
- Regression of Uterine Leiomyomata in Response to the Antiprogesterone RU 486 via openalex
- W2082692766 via openalex
- W2108976724 via openalex
- W2123015098 via openalex
- W2339185636 via openalex
- W2411716433 via openalex
- W2417930906 via openalex
- W2418875486 via openalex
- W4296792067 via openalex
- W6607566890 via openalex
- W186645392 via openalex
- W6662394256 via openalex
- W1968277161 via openalex
- W1974272316 via openalex
- W1979832282 via openalex
- W2037418840 via openalex
- W2064960854 via openalex
- W2073836271 via openalex
Cited by (22)
- Physiology of the Endometrium and Regulation of Menstruation 2020
- Progesterone Resistance and Targeting the Progesterone Receptors: A Therapeutic Approach to Endometriosis 2012
- Hormone therapy for endometriosis and surgical menopause 2009
- Newer treatment modalities in endometriosis: systematic review 2009
- Effects of Antiprogestins on the Uterus 2008
- Effects of the Progesterone Receptor Modulator VA2914 in a Continuous Low Dose on the Hypothalamic-Pituitary-Ovarian Axis and Endometrium in Normal Women: A Prospective, Randomized, Placebo-Controlled Trial 2007
- Progesterone receptor modulators and the endometrium: changes and consequences† 2007
- Inhibition of Proliferation of Endometrial Stromal Cells by Trichostatin A, RU486, CDB-2914, N-Acetylcysteine, and ICI 182780 2006
- Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications 2005
- Effects of Hormones 2005
- Selective Progesterone Receptor Modulator Development and Use in the Treatment of Leiomyomata and Endometriosis 2005
- Effect of long-term treatment with low-dose mifepristone on the endometrium 2003
- Progesterone antagonists and progesterone receptor modulators: an overview 2003
- Role of Progesterone Antagonists and New Selective Progesterone Receptor Modulators in Reproductive Health 2002
- Daily Low-Dose Mifepristone Has Contraceptive Potential by Suppressing Ovulation and Menstruation: A Double-Blind Randomized Control Trial of 2 and 5 mg per Day for 120 Days 2002
- Progesterone receptor modulators and progesterone antagonists in women's health 2000
- RU486-induced growth inhibition of human endometrial cells 2000
- MODERN MEDICAL MANAGEMENT OF ENDOMETRIOSIS 1997
- Mifepristone: Clinical Application in General Gynecology 1996
- Antiprogestin and/or gonadotropin-releasing hormone agonist for endometriosis treatment and bone maintenance: a 1-year primate study. 1996
- Pharmacokinetics of mifepristone after low oral doses 1996
- Antiprogestins: Mechanism of Action and Contraceptive 1996
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:11:13.665691+00:00
License: CC0
· commercial use OK